Diabetes, metabolic diseases
Conditions
Interventions
Intervention type:
Name of intervention:
Dose form / Japanese Medical Device Nomenclature:
Route of administration / Site of application:
Dose per administration:
Dosing frequency / Frequency of use:
Sponsors
Hidetaka Hamasaki
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with diabetes who are 20 years of age or older.
Exclusion criteria
Exclusion criteria: Patients with pacemakers. Patients after extremity amputation. Patients who decline in ADL function and cannot be measured body composition by a bioelectrical impedance analysis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Death, cardiovascular events, and hospitalizations. | — |
Secondary
| Measure | Time frame |
|---|---|
| Associations between body composition and metabolic parameters at baseleine. Changes in glycemic control, lipid profile, and blood pressure. Progression of atherosclerosis and diabetic complications. | — |
Countries
Japan
Contacts
Public ContactHidetaka Hamasaki
Hamasaki Cliinic
Outcome results
None listed